NBIX Latest Headlines

Analysts Have Conflicting Sentiments on These Healthcare Companies: NexImmune (OtherNEXI), Legend Biotech (LEGN) and Neurocrine (NBIX)

at www.tipranks.com (Fri, 6-Nov 2:20 AM)

Analysts Offer Insights on Healthcare Companies: HealthStream (HSTM), Neurocrine (NBIX) and HeartBeam (BEAT)

at www.tipranks.com (Wed, 4-Nov 12:00 PM)

Wall Street Analysts Are Bullish on Top Healthcare Picks

at www.tipranks.com (Wed, 4-Nov 8:40 AM)

Integration Risks and Legacy Liabilities Threaten Neurocrine Biosciences’ Value Capture from Soleno Acquisition

at www.tipranks.com (Wed, 4-Nov 1:02 AM)

NBIX jumps after Q3 revenue grew 41% to $1.12B and INGREZZA sales guidance moved up to $2.9–$2.93B

Market Chameleon (Tue, 3-Nov 10:58 AM)

Neurocrine climbs after Q3 beat, guidance hike

at seekingalpha.com (Tue, 3-Nov 2:36 PM)

Analysts Offer Insights on Healthcare Companies: Hinge Health, Inc. Class A (HNGE), Neurocrine (NBIX) and SI-Bone (SIBN)

at www.tipranks.com (Tue, 3-Nov 1:10 PM)

Neurocrine Hold Maintained as Strong Execution Is Offset by Vykat XR Safety and Ingrezza Risks; $150 Target Unchanged

at www.tipranks.com (Tue, 3-Nov 10:15 AM)

Oppenheimer Remains a Buy on Neurocrine (NBIX)

at www.tipranks.com (Tue, 3-Nov 8:36 AM)

Analysts Are Bullish on These Healthcare Stocks: Neurocrine (NBIX), Travere Therapeutics (TVTX)

at www.tipranks.com (Tue, 3-Nov 8:10 AM)

Cantor Fitzgerald Reaffirms Their Buy Rating on Neurocrine (NBIX)

at www.tipranks.com (Tue, 3-Nov 7:58 AM)

Wells Fargo Gives a Buy Rating to Neurocrine (NBIX)

at www.tipranks.com (Tue, 3-Nov 7:56 AM)

Analysts Are Bullish on Top Healthcare Stocks: Tempus AI, Inc. Class A (TEM), Neurocrine (NBIX)

at www.tipranks.com (Tue, 3-Nov 7:51 AM)

NBIX Sets Nov. 2 Timeline for Q3 2026 Results: Release at 4:00 p.m. ET, Call at 4:30 p.m. ET

Market Chameleon (Tue, 13-Oct 11:51 AM)

NBIX Sets Nov. 2 Timeline for Q3 2026 Results, With Webcast Replay Archived for About a Month

Market Chameleon (Tue, 13-Oct 8:19 AM)

Over Half of KINECT-PRO Study Patients Achieved Remission With INGREZZA—Meaningful Improvements in Quality of Life Seen Across All Severity Levels

Market Chameleon (Wed, 12-Aug 8:44 AM)